Award

Delivery Order #SPE2DR26FBUS0

AmerisourceBergen Delivery Order for Hydroxyzine Tablets under Long-Term Pharmaceutical IDV

Buyer

Defense Logistics Agency

Award Amount

$83.34

Ceiling

$83.34

Awarded

March 03, 2026

Period of Performance

Mar 03, 2026 – Mar 04, 2026

Identifier

SPE2DR26FBUS0

NAICS

424210

This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading healthcare solutions and pharmaceutical distribution company. The order involves the procurement of Hydroxyzine HCL 25 MG Tablets, a pharmaceutical product essential for medical treatment. This specific delivery order is a subordinate procurement under a substantial Indefinite Delivery Vehicle (IDV) contract focused on pharmaceutical distribution services. The contract underscores the importance of dependable access to critical medications for healthcare providers, supporting public health infrastructure. The scope includes the timely delivery of the specified pharmaceutical product to the designated location in Conshohocken, Pennsylvania, within a short performance window. The contract was awarded as a delivery order likely under the existing competitive framework established by the IDV, ensuring continuity and efficiency in supply chain operations. The performance period is brief, reflecting the prompt fulfillment of a targeted pharmaceutical need. This delivery order builds upon an ongoing, long-term partnership established by the parent IDV contract, facilitating streamlined procurement and distribution processes critical to the agency's pharmaceutical needs.

Description

4571017499!HYDROXYZINE HCL 25 MG TABLET 500S

View original record